Search
forResearch 10 of 1000+
- Treatment of Alopecia Areata with Anti-Interferon-γ Antibodies
- Dystrophic-Anagen Effluvium Occurring During Pegylated Interferon-α-2a/Ribavirin Therapy
- Anticytokine therapy, particularly anti-IFN-γ, in Th1-mediated autoimmune diseases
- Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment
- 219 Clinical and immunological impact of booster immunization with recombinant mRNA vaccines for SARS-CoV-2 in patients with pemphigus and bullous pemphigoid
- An update of anti-viral treatment of COVID-19
- Interferon in the treatment of cutaneous T-cell lymphoma
- Interferon alfa-2a in the treatment of cutaneous T cell lymphoma
- Thyroid antibodies in Hashimoto’s thyroiditis patients are positively associated with inflammation and multiple symptoms
- Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection